Ipas MVA plus versus Wallach Endocell in women with abnormal uterine bleeding

Comparison of Tissue Adequacy for Histologic Examination from Ipas MVA plus® and Wallach Endocell® in Women with Abnormal Uterine Bleeding

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20140108001

Enrollment

428

Registered

2014-01-08

Start date

2014-01-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal uterine bleeding Abnormal uterine bleeding endometrial biopsy manual vacumm aspiration tissue adequacy

Interventions

Manual vacuum aspiration of endometrial tissue,Biopsy sampling of endometrial tissue

Experimental Device,Experimental Device

Ipas MVA plus&reg

,Wallach Endocell&reg

Eligibility

Sex/Gender

Female

Age

35 Years to 90 Years

Inclusion criteria

Inclusion criteria: Women aged > or = 35 years with abnormal uterine bleeding

Exclusion criteria

Exclusion criteria: Women with: 1. Pregnancy 2. active pelvic inflammatory disease 3. coagulopathy 4. cervical stenosis 5. Known case of cervical or uterine cancers

Design outcomes

Primary

Measure	Time frame
Tissue adequacy Histologic examination	—

Secondary

Measure	Time frame
Pain Wong-Baker faces pain rating scale,post procedure Complication percentages	—

Countries

THailand

Contacts

Public ContactArinporn Imruetaicharoenchok

Navamindradhiraj university

oh_dorae@hotmail.com66-81-9425406

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026